Psychiatric comorbidity in young heroin users

Drug and Alcohol Dependence

Volumn 84, Issue 1, 2006, Pages 48-55

  Rodriguez Llera M C ^a   Domingo Salvany, Antònia ^a   Brugal, M T ^b   Silva, T C ^c   Sanchez Niubo A ^a   Torrens, M ^a  

^a INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^b AGÈNCIA DE SALUT PÚBLICA DE BARCELONA   (Spain)

^c CARLOS III INSTITUTE OF HEALTH   (Spain)

Author keywords

Gender; Psychiatric comorbidity; Substance use treatment; Young populations

Indexed keywords

COCAINE; DIAMORPHINE;

ADULT; AGE DISTRIBUTION; ANOREXIA; ANTISOCIAL BEHAVIOR; ANXIETY DISORDER; ARTICLE; BORDERLINE STATE; BULIMIA; COCAINE DEPENDENCE; COMORBIDITY; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG USE; EATING DISORDER; FEMALE; GENERALIZED ANXIETY DISORDER; HEROIN DEPENDENCE; HUMAN; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MOOD CHANGE; MOOD DISORDER; PANIC; PREVALENCE; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; SAMPLE SIZE; SCHIZOPHRENIA; SEMI STRUCTURED INTERVIEW; SEX RATIO; SNOWBALL SAMPLE; SOCIAL PHOBIA; SUBSTANCE ABUSE;

ADOLESCENT; ADULT; AGE OF ONSET; COMORBIDITY; CRIME; DEMOGRAPHY; FEMALE; HEROIN DEPENDENCE; HUMANS; MALE; MASS SCREENING; MENTAL DISORDERS; PREVALENCE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION;

EID: 33746708801     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2005.11.025     Document Type: Article

References (31)

1. Brooner R.K., King V.L., Kidorf M., Schmidt Jr. C.W., and Bigelow G.E. Psychiatric and substance use comorbidity among treatment seeking opioid users. Arch. Gen. Psychiatry 54 (1997) 71-80
2. Cacciola J., Alterman A., Rutherford M., McKay J., and Mulvaney F. The relationship of psychiatric comorbidity to treatment outcomes in methadone maintained patients. Drug Alcohol Depend. 61 (2001) 271-280
3. Caton C.L., Drake R.E., Hasin D.H., Dominguez B., Shrout P.E., Samet S., and Schanzer W.B. Differences between early-phase primary psychotic disorders with concurrent substance use and substance-induced psychoses. Arch. Gen. Psychiatry 62 (2005) 137-145
4. Chen C.C., Tsai S.Y., Su L.W., Yang T.W., Tsai C.J., and Hwu H.G. Psychiatric co-morbidity among male heroin addicts: differences between hospital and incarcerated subjects in Taiwan. Addiction 94 (1999) 825-832
5. Darke S., Hall W., Wodak A., Heather N., and Ward J. Development and validation of a multi-dimensional instrument for assessing outcome of treatment among opiate users: the Opiate Treatment Index. Br. J. Addict. 87 (1992) 733-742
6. Eland-Goossensen M.A., van de Goor L.A.M., Garretsen H.F.L., and Schudel W.J. Opiate addicts in and outside treatment compared on psychopathology. Eur. Addict. Res. 3 (1997) 164-172
7. The ESEMeD/MHEDEA 2000 Investigators. Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatry Scand. 109 Suppl. 420 (2004) 21-27
8. First M.B., Spitzer R.L., Gibbon M., and Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders-Clinician Version (SCID-IV) (1997), American Psychiatric Press, Inc., Washington
9. de la Fuente L., Brugal M.T., Ballesta R., Bravo M.J., Barrio G., Domingo-Salvany A., Silva do Rosario T., Ambrós M.y., and Grupo del Proyecto ITINERE. Metodología del estudio de cohortes del Proyecto ITINERE sobre consumidores de heroína en tres ciudades españolas y características básicas de los participantes vol. 79 (2005), Rev. Esp. Salud Publica. pp. 475-491
10. Grant B.F., Stinson F.S., Dawson D.A., Chou S.P., and Ruan W.J. Co-occurrence of DSM-IV personality disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Compr. Psychiatry 46 (2005) 1-5
11. Hartnoll R., Griffits P., Taylor C., Hendrick V., Blanken P., and Nolimal D. Handbook on Snowball Sampling (1997), Pompidou Group, Council of Europe, Strasbourg
12. Hasin D., Nunes E., and Meydan J. Comorbidity of alcohol, drug and psychiatric disorders: epidemiology. In: En H.R., Kranzler J.A., and Tinsley (Eds). Dual Diagnosis and Psychiatric Treatment: Substance Abuse and Comorbid Disorders (2004), Marcel Dekker Inc., New York 1-33
13. Hasin D., Samet S., Nunes E., Meydan J., Matseoane K., and Waxman R. Diagnosis of comorbid disorders in substance users: Psychiatric Research Interview for Substance and Mental Disorders (PRISM-IV). Am. J. Psychiatry 163 (2006) 689-696
14. Hernandez-Avila C.A., Rounsaville B.J., and Kranzler H.R. Opioid-, cannabis- and alcohol-dependent women show more rapid progression to substance abuse treatment. Drug Alcohol Depend. 74 (2004) 265-272
15. Janca A., Ustun T.B., and Sartorius N. New versions of World Health Organization instruments for the assessment of mental disorders. Acta Psychiatry Scand. 90 (1994) 73-83
16. Kidorf M., Disney E.R., King V.L., Neufeld K., Beilenson P.L., and Brooner R.K. Prevalence of psychiatric and substance use disorders in opioid abusers in a community syringe exchange program. Drug Alcohol Depend. 74 (2004) 115-122
17. King V.L., Kidorf M.S., Stoller K.B., and Brooner R.K. Influence of psychiatric comorbidity on HIV risk behaviors: changes during drug abuse treatment. J. Addict. Dis. 19 (2000) 65-83
18. Krausz M., Degkwitz P., Kühne A., and Verthein U. Comorbidity of opiate dependence and mental disorders. Addict. Behav. 23 (1998) 767-783
19. Krausz M., Verthein U., and Degkwitz P. Psychiatric comorbidity in opiate addicts. Eur. Addict. Res. 5 (1999) 55-62
20. Marsden J., Gossop M., Stewart D., Best D., Farrell M., Lehmann P., Edwards C., and Strang J. The Maudsley Addiction Profile (MAP): a brief instrument for assessing treatment outcome. Addiction 93 (1998) 1857-1867
21. Mason B., Kocsis J., Melia D., Khuri E., Sweeney J., Wells A., Borg L., Millman R., and Kreek M. Psychiatric comorbidity in methadone maintained patients. J. Addict. Dis. 17 (1998) 75-89
22. McLellan A.T., Kushner H., Metzger D., Peters R., Smith I., Grissom G., Pettinati H., and Argeriou M. The fifth edition of the addiction severity index. J. Subst. Abuse Treat. 9 (1992) 199-213
23. Rounsaville B., and Kleber H. Untreated opiate addicts: how do they differ from those seeking treatment?. Arch. Gen. Psychiatry 42 (1985) 1072-1077
24. Rounsaville B.J., Kranzler H.R., Ball S., Tennen H., Poling J., and Triffleman E. Personality disorders in substance abusers: relation to substance use. J. Nerv. Ment. Dis. 186 (1998) 87-95
25. Sinha R., and Rounsaville B.J. Sex differences in depressed substance abusers. J. Clin. Psychiatry 63 (2002) 616-627
26. Spitzer R.L. Psychiatric diagnosis: are clinicians still necessary?. Compr. Psychiatry 24 (1983) 399-411
27. Suelves J.M., Brugal M.T., Caylà J.A., and Torralba L. Change in health-related problems of cocaine consumption in Catalonia, Spain. Med. Clin. (Barc.) 117 (2001) 581-583
28. Torrens M., Serrano D., Astals M., Pérez-Domínguez G., and Martín-Santos R. Diagnosing psychiatric comorbidity in substance abusers. Validity of the Spanish versions of Psychiatric Research Interview for Substance and Mental Disorders (PRISM-IV) and the Structured Clinical Interview for DSM-IV (SCID-IV). Am. J. Psychiatry 161 (2004) 1231-1237
29. Watters J.K., and Biernacki P. Targeted sampling: options for the study of hidden populations. Soc. Probl. 36 (1989) 416-430
30. Westermeyer J., and Thuras P. Association of antisocial personality disorder and substance disorder mortbidity in a clinical sample. Am. J. Drug Alcohol Abuse 31 (2005) 93-110
31. World Health Organization (WHO), 1998. Composite International Diagnostic Interview (CIDI): Core, Version 2.1.